ADVERTISEMENT

From the Desk of the CEO

Empowering Pharmacy Voices, Inspiring Change

Discover insights, stories, and expertise from pharmacists shaping the future of healthcare. Explore thought-provoking discussions, industry trends, and personal experiences that define the pharmacy profession.

Posted: Jan 18, 2022

FDA warns of dental problems associated with certain buprenorphine medications

FDA is drawing attention to dental problems linked to buprenorphine-containing medications that are dissolved under the tongue or placed against the inside of the cheek to treat opioid use disorder and pain.

Read more
Posted: Jan 14, 2022

Polypharmacy, certain medication classes seem to worsen COVID-19 outcomes

Pharmacists are well aware that polypharmacy is a major issue among patients, especially older adults. Recent studies have estimated that approximately 36% of older adults take at least 5 prescription medications, and 67% take 5 or more medications or supplements, including OTCs.

Read more
Posted: Jan 11, 2022

ISMP issues warning about possible safety issues with newly authorized antiviral

To encourage the appropriate use of Pfizer’s COVID-19 antiviral drug nirmatrelvir/ritonavir (Paxlovid), the Institute for Safe Medication Practices (ISMP) released an alert for dispensing pharmacists.

Read more
Posted: Jan 11, 2022

Many patients not receiving statins after lower-extremity revascularization

A new study in JAMA Network Open analyzed data from more than 125,000 patients who received lower-extremity revascularization between 2014 and 2019.

Read more
Posted: Jan 10, 2022

New HIV PrEP guidelines call for clinicians to talk with patients about prevention meds

CDC now advises all clinicians to talk to their patients who are sexually active, including adolescents, about HIV preexposure prophylaxis (PrEP) at least once and to prescribe the prevention medication to anyone who requests them.

Read more
245678910Last
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT